The demand for minimal residual disease testing is increasing mainly due to the higher prevalence of solid tumors and blood cancers like leukemia, multiple myeloma, and lymphoma. Continuous advances ...

Some of the country’s poorest and remotest regions, which have fewer health facilities, have logged more leptospirosis deaths ...